Cargando…

Prognostic role of plasma fibrinogen in patients with uterine leiomyosarcoma – a multicenter study

Fibrinogen has an important pathophysiological role in tumor cell progression and development of metastases in different types of cancer. The present study aimed to evaluate the role of pre-treatment fibrinogen plasma concentrations as a biomarker for tumor biology and prognosis in patients with ute...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bekos, Christine, Grimm, Christoph, Brodowicz, Thomas, Petru, Edgar, Hefler, Lukas, Reimer, Daniel, Koch, Horst, Reinthaller, Alexander, Polterauer, Stephan, Polterauer, Mariella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670177/ https://www.ncbi.nlm.nih.gov/pubmed/29101329 http://dx.doi.org/10.1038/s41598-017-13934-8

Ejemplares similares

Gamma-glutamyltransferase as novel biomarker in patients with uterine leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2016)

The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma
por: Schwameis, Richard, et al.
Publicado: (2015)

Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma
por: Lamm, Wolfgang, et al.
Publicado: (2014)

The Prognostic Value of the Fibrinogen-Albumin-Ratio Index (FARI) in Patients with Advanced Vulvar Cancer
por: Onoprienko, Arina, et al.
Publicado: (2022)

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial
por: Seebacher, V, et al.
Publicado: (2010)

Prognostic value of serum creatine level in patients with vulvar cancer
por: Schwameis, Richard, et al.
Publicado: (2019)

The prognostic value of four interleukin-1 gene polymorphisms in caucasian women with breast cancer – a multicenter study
por: Grimm, Christoph, et al.
Publicado: (2009)

The Pretreatment Controlling Nutritional Status Score in Ovarian Cancer: Influence on Prognosis, Surgical Outcome, and Postoperative Complication Rate
por: Bekos, Christine, et al.
Publicado: (2022)

Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature
por: Mailath-Pokorny, Mariella, et al.
Publicado: (2016)

Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis
por: Bekos, Christine, et al.
Publicado: (2018)

Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen
por: Seebacher, Veronika, et al.
Publicado: (2017)

The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study
por: Seebacher, Veronika, et al.
Publicado: (2009)

Corrected Allele Frequency of BRCA1/2 Mutations Is an Independent Prognostic Factor for Treatment Response to PARP-Inhibitors in Ovarian Cancer Patients
por: Grech, Christina T., et al.
Publicado: (2022)

The impact of lymph node density on survival of cervical cancer patients
por: Polterauer, S, et al.
Publicado: (2010)

Pre-operative hypoalbuminemia is associated with complication rate and overall survival in patients with vulvar cancer undergoing surgery
por: Bekos, Christine, et al.
Publicado: (2019)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

Reply: Lymph node density as a surrogate marker for positive lymph nodes
por: Polterauer, S, et al.
Publicado: (2011)

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
por: Bekos, Christine, et al.
Publicado: (2021)

A collagen-fibrin patch (Tachosil®) for the prevention of symptomatic lymphoceles after pelvic lymphadenectomy in women with gynecologic malignancies: a randomized clinical trial
por: Grimm, Christoph, et al.
Publicado: (2014)

Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
por: Paspalj, V., et al.
Publicado: (2021)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
por: Bekos, Christine, et al.
Publicado: (2021)

Factors associated with post-relapse survival in patients with recurrent cervical cancer: the value of the inflammation-based Glasgow Prognostic Score
por: Seebacher, Veronika, et al.
Publicado: (2018)

AGO Austria recommendations for genetic testing of patients with ovarian cancer
por: Marth, Christian, et al.
Publicado: (2015)

Notching and Pulsatility Index of the Uterine Arteries and Preeclampsia in Twin Pregnancies
por: Springer, Stephanie, et al.
Publicado: (2020)

The Impact of the Duration of Adjuvant Chemotherapy on Survival in Patients with Epithelial Ovarian Cancer – A Retrospective Study
por: Seebacher, Veronika, et al.
Publicado: (2017)

Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2022)

Increased genitourinary fistula rate after bevacizumab in recurrent cervical cancer patients initially treated with definitive radiochemotherapy and image-guided adaptive brachytherapy
por: Sturdza, Alina, et al.
Publicado: (2017)

The value of pretreatment serum butyrylcholinesterase level as a novel prognostic biomarker in patients with cervical cancer treated with primary (chemo-)radiation therapy
por: Poetsch, Nina, et al.
Publicado: (2019)

Impact of frailty on the management of patients with gynecological cancer aged 80 years and older
por: Reiser, Elisabeth, et al.
Publicado: (2020)

AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS)
por: Zeimet, Alain G., et al.
Publicado: (2017)

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2015)

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data
por: Oberndorfer, Felicitas, et al.
Publicado: (2021)

The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
por: Aust, Stefanie, et al.
Publicado: (2013)

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

AB0 blood groups and rhesus factor expression as prognostic parameters in patients with epithelial ovarian cancer – a retrospective multi-centre study
por: Seebacher, Veronika, et al.
Publicado: (2018)

NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach
por: Bekos, Christine, et al.
Publicado: (2019)

Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2020)

Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial
por: Seebacher, V, et al.
Publicado: (2013)

Successful one-stage resection of intracardiac intravenous leiomyomatosis: A case report
por: Magdalena, Postl, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2hfn17bjijc68clas4rekq7e29